Some studies show that high expression of the SETD3 gene is associated with poor survival in triple-negative breast cancer [19], while HOXB3 and FOXA1 were identified as indicators of better prognosis [20–22]. This evidence concerns the gene SETD3 and triple-negative breast carcinoma.